The U-BIOPRED consortium includes representatives of all stakeholder groups by involving 20 academic institutions, 11 biopharma industry partners (EFPIA), 6 patient organisations, 3 small to medium enterprises and 1 multinational industry, in 11 European countries.
The project is co-ordinated by the Academic Medical Centre, University of Amsterdam, The Netherlands. Professor Peter Sterk is the project leader.
The EFPIA (European Federation of Pharmaceutical Industries and Associations) co-ordinator is Novartis Pharma AG.
Patients have been involved at all stages of the project: as members of the Ethics Board (EB) and Safety Monitoring Boards (SMB), in the Patient Involvement Platform (PIP), and as participants.